The science
The brightening logic of this serum is sound in outline and untested in detail. Its two best-placed actives, niacinamide and tranexamic acid, work at different points in the pigment pathway: niacinamide reduces the transfer of melanosomes from melanocytes to keratinocytes and has controlled evidence at 2 to 5 percent for lightening hyperpigmentation, while tranexamic acid, a synthetic lysine analogue, blocks the conversion of plasminogen to plasmin in keratinocytes and thereby lowers the arachidonic-acid and melanocyte-stimulating signals that drive melasma. The topical tranexamic evidence is mixed but real: a 2012 double-blind, randomised, split-face trial in the Journal of Cosmetic and Laser Therapy applied 5 percent tranexamic acid gel versus vehicle twice daily for twelve weeks to 23 women with epidermal melasma and found melanin index and MASI scores fell significantly on both sides, with the tranexamic side not clearly superior to vehicle and showing more erythema, which is an honest signal that topical tranexamic acid is both modestly active and mildly irritating. Later trials pairing tranexamic acid with niacinamide, sometimes in liposomal or niosomal vehicles, have reported results comparable to 4 percent hydroquinone, which is the basis for the combination's popularity. Kojic acid is a well-characterised tyrosinase inhibitor with clinical support at 1 to 4 percent, and a well-documented rate of allergic contact dermatitis with prolonged use; hydroxyphenoxy propionic acid, sold as Radianskin, is a structural relative of hydroquinone that inhibits tyrosinase without hydroquinone's melanocyte toxicity and has supplier-generated data showing spot lightening at 1 percent. Acetyl glucosamine has small trials showing additive benefit with niacinamide for facial pigment. The exfoliant group is where the formula's tolerance problem lives: glycolic acid and salicylic acid are both active at the low pH such a serum needs, gluconolactone is a milder polyhydroxy acid, and together with acetyl glucosamine they increase desquamation and transepidermal water loss, which compounds the erythema tranexamic and kojic acids already cause. On skin of colour, that irritation is a recognised trigger of post-inflammatory hyperpigmentation, an outcome directly opposed to the product's purpose. None of the eight actives is dosed, and in 29ml of water serum they cannot all be at effective concentrations. The science supports the niacinamide-tranexamic core as a reasonable over-the-counter approach to superficial pigment, supports the exfoliant load as a source of irritation, and does not support the clinically proven claim attached to the trademarked ingredient.
References 1 ShowHide
- Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial — Journal of Cosmetic and Laser Therapy (2012)